BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30305539)

  • 1. [2018 update on chronic graft-versus-host disease].
    Inamoto Y
    Rinsho Ketsueki; 2018; 59(10):2300-2306. PubMed ID: 30305539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials.
    Pavletic SZ; Lee SJ; Socie G; Vogelsang G
    Bone Marrow Transplant; 2006 Nov; 38(10):645-51. PubMed ID: 16980994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
    Shulman HM; Kleiner D; Lee SJ; Morton T; Pavletic SZ; Farmer E; Moresi JM; Greenson J; Janin A; Martin PJ; McDonald G; Flowers ME; Turner M; Atkinson J; Lefkowitch J; Washington MK; Prieto VG; Kim SK; Argenyi Z; Diwan AH; Rashid A; Hiatt K; Couriel D; Schultz K; Hymes S; Vogelsang GB
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):31-47. PubMed ID: 16399567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
    Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.
    Chronic GVHD Consortium
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1727-1732. PubMed ID: 29476954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of graft-versus-host disease].
    Ozawa Y
    Rinsho Ketsueki; 2020; 61(9):1395-1401. PubMed ID: 33162541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
    Cuvelier GDE; Schoettler M; Buxbaum NP; Pinal-Fernandez I; Schmalzing M; Distler JHW; Penack O; Santomasso BD; Zeiser R; Angstwurm K; MacDonald KPA; Kimberly WT; Taylor N; Bilic E; Banas B; Buettner-Herold M; Sinha N; Greinix HT; Pidala J; Schultz KR; Williams KM; Inamoto Y; Cutler C; Griffith LM; Lee SJ; Sarantopoulos S; Pavletic SZ; Wolff D
    Transplant Cell Ther; 2022 Aug; 28(8):426-445. PubMed ID: 35662591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
    Vigorito AC; Campregher PV; Storer BE; Carpenter PA; Moravec CK; Kiem HP; Fero ML; Warren EH; Lee SJ; Appelbaum FR; Martin PJ; Flowers ME;
    Blood; 2009 Jul; 114(3):702-8. PubMed ID: 19470693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
    Wolff D; Radojcic V; Lafyatis R; Cinar R; Rosenstein RK; Cowen EW; Cheng GS; Sheshadri A; Bergeron A; Williams KM; Todd JL; Teshima T; Cuvelier GDE; Holler E; McCurdy SR; Jenq RR; Hanash AM; Jacobsohn D; Santomasso BD; Jain S; Ogawa Y; Steven P; Luo ZK; Dietrich-Ntoukas T; Saban D; Bilic E; Penack O; Griffith LM; Cowden M; Martin PJ; Greinix HT; Sarantopoulos S; Socie G; Blazar BR; Pidala J; Kitko CL; Couriel DR; Cutler C; Schultz KR; Pavletic SZ; Lee SJ; Paczesny S
    Transplant Cell Ther; 2021 Oct; 27(10):817-835. PubMed ID: 34217703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.
    Paczesny S; Hakim FT; Pidala J; Cooke KR; Lathrop J; Griffith LM; Hansen J; Jagasia M; Miklos D; Pavletic S; Parkman R; Russek-Cohen E; Flowers ME; Lee S; Martin P; Vogelsang G; Walton M; Schultz KR
    Biol Blood Marrow Transplant; 2015 May; 21(5):780-92. PubMed ID: 25644957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.
    Lee SJ; Wolff D; Kitko C; Koreth J; Inamoto Y; Jagasia M; Pidala J; Olivieri A; Martin PJ; Przepiorka D; Pusic I; Dignan F; Mitchell SA; Lawitschka A; Jacobsohn D; Hall AM; Flowers ME; Schultz KR; Vogelsang G; Pavletic S
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):984-99. PubMed ID: 25796139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
    Jagasia MH; Greinix HT; Arora M; Williams KM; Wolff D; Cowen EW; Palmer J; Weisdorf D; Treister NS; Cheng GS; Kerr H; Stratton P; Duarte RF; McDonald GB; Inamoto Y; Vigorito A; Arai S; Datiles MB; Jacobsohn D; Heller T; Kitko CL; Mitchell SA; Martin PJ; Shulman H; Wu RS; Cutler CS; Vogelsang GB; Lee SJ; Pavletic SZ; Flowers ME
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):389-401.e1. PubMed ID: 25529383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
    Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
    Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.
    DeFilipp Z; Couriel DR; Lazaryan A; Bhatt VR; Buxbaum NP; Alousi AM; Olivieri A; Pulanic D; Halter JP; Henderson LA; Zeiser R; Gooley TA; MacDonald KPA; Wolff D; Schultz KR; Paczesny S; Inamoto Y; Cutler CS; Kitko CL; Pidala JA; Lee SJ; Socie G; Sarantopoulos S; Pavletic SZ; Martin PJ; Blazar BR; Greinix HT
    Transplant Cell Ther; 2021 Sep; 27(9):729-737. PubMed ID: 34147469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
    Pidala J; Kitko C; Lee SJ; Carpenter P; Cuvelier GDE; Holtan S; Flowers ME; Cutler C; Jagasia M; Gooley T; Palmer J; Randolph T; Levine JE; Ayuk F; Dignan F; Schoemans H; Tkaczyk E; Farhadfar N; Lawitschka A; Schultz KR; Martin PJ; Sarantopoulos S; Inamoto Y; Socie G; Wolff D; Blazar B; Greinix H; Paczesny S; Pavletic S; Hill G
    Transplant Cell Ther; 2021 Aug; 27(8):632-641. PubMed ID: 33836313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monogenic Immune Diseases Provide Insights Into the Mechanisms and Treatment of Chronic Graft-Versus-Host Disease.
    Rozmus J
    Front Immunol; 2020; 11():574569. PubMed ID: 33613511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease.
    Lee JW; Lee DH; Jang PS; Yi MS; Chung NG; Cho B; Jeong DC; Kim HK
    Yonsei Med J; 2011 Sep; 52(5):779-86. PubMed ID: 21786443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
    Pavletic SZ; Martin P; Lee SJ; Mitchell S; Jacobsohn D; Cowen EW; Turner ML; Akpek G; Gilman A; McDonald G; Schubert M; Berger A; Bross P; Chien JW; Couriel D; Dunn JP; Fall-Dickson J; Farrell A; Flowers ME; Greinix H; Hirschfeld S; Gerber L; Kim S; Knobler R; Lachenbruch PA; Miller FW; Mittleman B; Papadopoulos E; Parsons SK; Przepiorka D; Robinson M; Ward M; Reeve B; Rider LG; Shulman H; Schultz KR; Weisdorf D; Vogelsang GB;
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):252-66. PubMed ID: 16503494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.